+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Next-Generation Cancer Diagnostics Market by Product, Technology, Cancer Type, Function, Staging, Application, End-User - Global Forecast 2025-2030- Product Image
Next-Generation Cancer Diagnostics Market by Product, Technology, Cancer Type, Function, Staging, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Next-Generation Cancer Diagnostics Market by Product, Technology, Cancer Type, Function, Staging, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5311174
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The next-generation cancer diagnostics market is accelerating toward greater precision and integration, giving stakeholders critical tools to improve patient care and streamline operational efficiency. As the demand for advanced diagnostic solutions grows, innovations in sequencing technology, data analytics, and minimally invasive detection are redefining clinical pathways and competitive dynamics.

Market Snapshot: Cancer Diagnostics Innovation at Scale

The Next-Generation Cancer Diagnostics Market grew from USD 12.02 billion in 2024 to USD 15.03 billion in 2025. It is expected to continue expanding at a CAGR of 24.34%, reaching USD 44.47 billion by 2030. Market momentum is fueled by the convergence of molecular technologies, AI-driven analytics, and heightened focus on early detection, which together are empowering healthcare organizations to identify cancer at earlier stages and enable tailored patient management strategies.

Scope & Segmentation: Next-Generation Cancer Diagnostics Market

This report offers a comprehensive examination of the next-generation cancer diagnostics landscape, providing strategic segmentation and broad technology coverage:

  • Product Categories: Instruments (including analyzers and sequencers), reagents & consumables, software & services
  • Technology Platforms: DNA microarrays, protein microarrays, next-generation sequencing, qPCR & multiplexing, lab-on-a-chip, reverse transcriptase-PCR
  • Cancer Types: Breast, colorectal, lung, and prostate cancer, accounting for distinct clinical and biomarker profiles
  • Functions: Biomarker development, circulating tumor cell (CTC) analysis, epigenetic and genetic analysis, proteomic analysis
  • Staging: Early detection approaches and progressive staging tools
  • Applications: Cancer screening, companion diagnostics, prognostics, risk assessment, and therapeutic monitoring
  • End-User Groups: Diagnostic laboratories, hospitals, academic research institutes, governmental agencies
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (featuring United Kingdom, Germany, France, and others), Asia-Pacific (notably China, India, Japan, Australia, and additional key economies)
  • Company Coverage: Leading companies such as Abbott Laboratories, Thermo Fisher Scientific, Illumina, Agilent Technologies, Danaher, Siemens Healthineers, and other prominent industry participants

Key Takeaways: Strategic Insights for Senior Leaders

  • The market’s advancement is propelled by the integration of molecular profiling, liquid biopsy, and artificial intelligence, delivering refined detection and decision support capabilities for clinicians.
  • Regulatory evolution, including expedited approval pathways and reimbursement policy updates, is supporting faster commercialization and greater clinical adoption of novel diagnostics.
  • Strategic partnerships across instrument manufacturers, software developers, and reagent suppliers are enabling the creation of comprehensive, end-to-end solutions tailored to diverse user needs.
  • Regional variations in healthcare infrastructure and reimbursement models drive differing adoption trajectories, with emerging markets showing rising demand due to public screening initiatives and investment in laboratory capacity.
  • Competitive dynamics are increasingly influenced by agile start-ups, disruptive assay formats, and cloud-native analytics, raising the standard for speed, accuracy, and patient-centric diagnostics.

Tariff Impact: Navigating U.S. Policy Shifts in Cancer Diagnostic Supply Chains

Recent U.S. tariff adjustments have introduced pressures on the global cancer diagnostics supply chain. Duties on imported instruments, reagents, and consumables have increased landed costs and challenged sourcing strategies within the sector. Companies are responding through localized production, strengthened relationships with domestic suppliers, and operational adjustments to protect margins and supply continuity, underscoring the importance of resilient and agile supply chain management.

Methodology & Data Sources

Insights in this report combine primary interviews with senior industry executives and clinical leaders alongside thorough secondary research, including peer-reviewed studies, regulatory databases, public company filings, and market announcements. Data triangulation and peer review enhance validity, ensuring robust, up-to-date perspectives on prevailing and emerging trends.

Why This Report Matters

  • Delivers actionable, detailed segmentation to inform product pipeline prioritization and go-to-market strategy.
  • Unpacks regulatory, technological, and competitive shifts so leaders can anticipate change and invest with confidence.
  • Equips senior decision-makers with clear insights to optimize operational efficiency, supply chain resilience, and market positioning amid evolving industry forces.

Conclusion

Next-generation cancer diagnostics are shaping a future defined by earlier detection, tailored treatments, and operational agility. Forward-looking leaders equipped with robust insights can drive transformational patient outcomes and sustained business growth in this dynamic market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of liquid biopsy platforms for early detection of minimal residual disease with high sensitivity and specificity
5.2. Adoption of artificial intelligence-driven image analysis to improve tumor subtyping accuracy and prognostic predictions
5.3. Expansion of multiomics profiling workflows combining genomics proteomics and metabolomics to enable personalized oncology diagnostics
5.4. Emergence of point-of-care nanotechnology assays for rapid on-site quantification of cancer biomarkers in resource-limited settings
5.5. Implementation of digital twin modeling platforms to simulate tumor evolution and optimize individualized treatment strategies
5.6. Growth of companion diagnostic tests targeting emerging rare oncogenic mutations alongside novel targeted therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Next-Generation Cancer Diagnostics Market, by Product
8.1. Introduction
8.2. Instruments
8.2.1. Analyzers
8.2.2. Sequencers
8.3. Reagents & Consumables
8.4. Software & Services
9. Next-Generation Cancer Diagnostics Market, by Technology
9.1. Introduction
9.2. DNA Microarrays
9.3. Lab-on- a- chip & Reverse Transcriptase-PCR
9.4. Next-generation Sequencing
9.5. Protein Microarrays
9.6. qPCR & Multiplexing
10. Next-Generation Cancer Diagnostics Market, by Cancer Type
10.1. Introduction
10.2. Breast Cancer
10.3. Colorectal Cancer
10.4. Lung Cancer
10.5. Prostate Cancer
11. Next-Generation Cancer Diagnostics Market, by Function
11.1. Introduction
11.2. Biomarker Development
11.3. CTC Analysis
11.4. Epigenetic Analysis
11.5. Genetic Analysis
11.6. Proteomic Analysis
12. Next-Generation Cancer Diagnostics Market, by Staging
12.1. Introduction
12.2. Early Detection
12.3. Progressive Staging
13. Next-Generation Cancer Diagnostics Market, by Application
13.1. Introduction
13.2. Cancer Screening
13.3. Companion Diagnostics
13.4. Prognostics
13.5. Risk Assessment
13.6. Therapeutic Monitoring
14. Next-Generation Cancer Diagnostics Market, by End-User
14.1. Introduction
14.2. Diagnostic Laboratories
14.3. Hospitals
14.4. Research Institutes
14.4.1. Academic
14.4.2. Governmental
15. Americas Next-Generation Cancer Diagnostics Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Next-Generation Cancer Diagnostics Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Next-Generation Cancer Diagnostics Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. Adaptive Biotechnologies Corporation
18.3.3. Agena Bioscience, Inc. by Mesa Laboratories, Inc.
18.3.4. Agilent Technologies, Inc.
18.3.5. Akadeum Life Sciences
18.3.6. Almac Group
18.3.7. Becton, Dickinson & Company
18.3.8. Bio-Techne Corporation
18.3.9. Biological Dynamics Inc.
18.3.10. bioMérieux SA
18.3.11. BioNTech SE
18.3.12. Castle Biosciences Inc.
18.3.13. Danaher Corporation
18.3.14. Exact Sciences Corporation
18.3.15. F. Hoffmann-La Roche Ltd.
18.3.16. GE HealthCare
18.3.17. Hologic Inc.
18.3.18. Illumina, Inc.
18.3.19. Johnson & Johnson Services, Inc.
18.3.20. Konica Minolta, Inc.
18.3.21. Koninklijke Philips N.V.
18.3.22. NeoGenomics Laboratories
18.3.23. Novartis AG
18.3.24. OPKO Health, Inc.
18.3.25. Oxford Nanopore Technologies Limited
18.3.26. Perkin Elmer, Inc.
18.3.27. Qiagen N.V.
18.3.28. Siemens Healthineers AG
18.3.29. Sysmex Corporation
18.3.30. Telerad Tech
18.3.31. Thermo Fisher Scientific, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. NEXT-GENERATION CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. NEXT-GENERATION CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. NEXT-GENERATION CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. NEXT-GENERATION CANCER DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 30. NEXT-GENERATION CANCER DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 31. NEXT-GENERATION CANCER DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 32. NEXT-GENERATION CANCER DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEXT-GENERATION CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY DNA MICROARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY DNA MICROARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY LAB-ON- A- CHIP & REVERSE TRANSCRIPTASE-PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY LAB-ON- A- CHIP & REVERSE TRANSCRIPTASE-PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MICROARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PROTEIN MICROARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY QPCR & MULTIPLEXING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY QPCR & MULTIPLEXING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PROTEOMIC ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PROTEOMIC ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PROGRESSIVE STAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PROGRESSIVE STAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PROGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PROGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY ACADEMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY GOVERNMENTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY GOVERNMENTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 130. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 131. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 132. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 133. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 138. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 139. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 140. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 141. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 145. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 146. CANADA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 147. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 148. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 149. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 158. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 159. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 163. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 164. MEXICO NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 239. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 240. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 241. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 242. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 243. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 250. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 251. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 255. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 256. GERMANY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 257. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 258. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 259. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 260. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 261. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 266. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 268. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 269. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 272. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 273. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 274. FRANCE NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY STAGING, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 293. ITALY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 294. ITALY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 295. ITALY NEXT-GENERATION CANCER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 296. ITALY NEXT-GENERATION CANCER DIAGNOSTICS

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • Agena Bioscience, Inc. by Mesa Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Akadeum Life Sciences
  • Almac Group
  • Becton, Dickinson & Company
  • Bio-Techne Corporation
  • Biological Dynamics Inc.
  • bioMérieux SA
  • BioNTech SE
  • Castle Biosciences Inc.
  • Danaher Corporation
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare
  • Hologic Inc.
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • NeoGenomics Laboratories
  • Novartis AG
  • OPKO Health, Inc.
  • Oxford Nanopore Technologies Limited
  • Perkin Elmer, Inc.
  • Qiagen N.V.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Telerad Tech
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 15.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 44.47 Billion
Compound Annual Growth Rate24.3%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Next-Generation Gynecological Cancer Diagnostics Market by Technology, Application, Product, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Next-Generation Gynecological Cancer Diagnostics Market by Technology, Application, Product, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings (Digital Pathology, Imaging Technologies, Implantable Sensors), Test Type (Genetic Tests, Pathological Tests, Protein Marker Tests), Stage, Application, End User - Global Forecast 2025-2030 - Product Image

Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings (Digital Pathology, Imaging Technologies, Implantable Sensors), Test Type (Genetic Tests, Pathological Tests, Protein Marker Tests), Stage, Application, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033 - Product Image

Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2025-2033

  • Report
  • 145 Pages
  • Global
From
Next Generation Cancer Diagnostics - Global Strategic Business Report - Product Image

Next Generation Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 175 Pages
  • Global
From
Next Generation Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Next Generation Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Next Generation Cancer Diagnostics Market

The Next Generation Cancer Diagnostics market is a subset of the Diagnostics industry that focuses on the development of advanced technologies for the early detection and diagnosis of cancer. These technologies include molecular diagnostics, biomarkers, imaging, and other methods that can detect cancer at its earliest stages. This market is driven by the need for more accurate and timely diagnosis of cancer, as well as the increasing prevalence of the disease. The Next Generation Cancer Diagnostics market is expected to grow significantly in the coming years, driven by the increasing demand for early diagnosis and the development of new technologies. This market is also expected to benefit from the increasing availability of data and the development of artificial intelligence and machine learning. Some of the major players in the Next Generation Cancer Diagnostics market include Illumina, Thermo Fisher Scientific, Roche, Qiagen, and Agilent Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.